Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Buying Assets from Mexican Distributor

NEW YORK (GenomeWeb News) – Agilent Technologies has signed a definitive agreement to buy assets from ABC Instrumentacion Analitica, the two companies announced today.

Financial and other terms were not disclosed.

Based in Mexico City, ABCIA distributes analytical solutions, including Agilent's chemical analysis and life science products. It also provides sales, application support, and customer training for Agilent's products, such as mass spectrometers, liquid chromatographs, gas chromatographs, atomic and molecular spectroscopy systems, and bioanalyzers.

Upon completion of the deal, expected on Oct. 1, ABCIA customers in Mexico will have integrated sales and services directly from Agilent.

ABCIA was formed in 1986 to distribute Hewlett-Packard's analytical solutions and became an Agilent distributor when that firm was spun out of HP in 1999.

About 30 ABCI employees are anticipated to move to Agilent upon the completion of the acquisition, the companies said.

"As a unified team, we will provide a better customer experience by streamlining processes and delivering top-tier service in a consistent way," Sylvia Escobar, vice president in charge of field operations for Agilent's chemical analysis business in the Americas, said in a statement. "This acquisition also supports Agilent's aim to expand in the growing Mexican analytical market."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.